サマリー

抗凝固剤の世界市場 2023-2027 年
抗凝固剤市場は、2022年から2027年の間に18,091.94百万米ドル、予測期間中のCAGRは8.42%で加速して成長すると予測されます。当レポートでは、抗凝固剤市場の全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、新規経口抗凝固薬の導入、凝固障害の有病率の増加、股関節および膝関節手術の増加によって牽引されています。
Technavioの抗凝固剤市場は以下のようにセグメント化されています：
投与方法別
- 経口抗凝固薬
- 注射用抗凝固剤
タイプ別
- 第Xa因子阻害剤
- DTI類
- ヘパリン
- ビタミンK拮抗薬
地域別構成比
- 北アメリカ
- 欧州
- アジア
- その他の地域(ROW)
本調査では、抗凝固剤の解毒剤の登場が、今後数年間の抗凝固剤市場の成長を促進する主な要因の1つであるとしています。また、患者支援プログラムや新興国への関心の高まりは、市場の大きな需要につながるでしょう。
抗凝固剤市場に関するレポートは、以下の分野をカバーしています：
- 抗凝固剤市場のサイジング
- 抗凝固剤市場の予測
- 抗凝固剤市場の産業分析
本レポートでは、抗凝固剤市場の主要ベンダー（Abbott Laboratories、Amphastar Pharmaceuticals Inc.、Aspen Pharmacare Holdings Ltd、AstraZeneca PLC、Bayer AG、Boehringer Ingelheim International GmbH、Bristol Myers Squibb Co.、第一三共 Co.Ltd.、Dr Reddys Laboratories Ltd.、GlaxoSmithKline Plc、Johnson and Johnson Services Inc.、Laboratorios Farmaceuticos ROVI S A、LEO Pharma AS、Novartis AG、Pfizer Inc.、Sanofi SA、 Shenzhen Hepalink Pharmaceutical Co.Ltd.、Teva Pharmaceutical Industries Ltd.、United Therapeutics Corp.などです。また、抗凝固剤市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - https://www.technavio.com/report/anticoagulants-market-industry-analysis
本書は、利益、価格、競争、プロモーションなどの主要なパラメータを分析し、複数のソースからのデータを調査、合成、要約することによって、市場の詳細なイメージを提示します。業界の主要なインフルエンサーを特定することで、さまざまな市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。市場調査レポートでは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global anticoagulants market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global anticoagulants market 2017 - 2021 ($ million)
o 4.2 Route of Administration Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Oral anticoagulants - Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral anticoagulants - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral anticoagulants - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral anticoagulants - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral anticoagulants - Year-over-year growth 2022-2027 (%)
o 6.4 Injectable anticoagulants - Market size and forecast 2022-2027
o Exhibit 38: Chart on Injectable anticoagulants - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Injectable anticoagulants - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Injectable anticoagulants - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Injectable anticoagulants - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
o Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 44: Chart on Type - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 46: Chart on Comparison by Type
o Exhibit 47: Data Table on Comparison by Type
o 7.3 Factor Xa inhibitors - Market size and forecast 2022-2027
o Exhibit 48: Chart on Factor Xa inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Factor Xa inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Factor Xa inhibitors - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Factor Xa inhibitors - Year-over-year growth 2022-2027 (%)
o 7.4 DTIs - Market size and forecast 2022-2027
o Exhibit 52: Chart on DTIs - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on DTIs - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on DTIs - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on DTIs - Year-over-year growth 2022-2027 (%)
o 7.5 Heparin - Market size and forecast 2022-2027
o Exhibit 56: Chart on Heparin - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Heparin - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Heparin - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Heparin - Year-over-year growth 2022-2027 (%)
o 7.6 Vitamin K antagonists - Market size and forecast 2022-2027
o Exhibit 60: Chart on Vitamin K antagonists - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Vitamin K antagonists - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Vitamin K antagonists - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Vitamin K antagonists - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Type
o Exhibit 64: Market opportunity by Type ($ million)
o Exhibit 65: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories - Overview
o Exhibit 116: Abbott Laboratories - Business segments
o Exhibit 117: Abbott Laboratories - Key news
o Exhibit 118: Abbott Laboratories - Key offerings
o Exhibit 119: Abbott Laboratories - Segment focus
o 12.4 Aspen Pharmacare Holdings Ltd
o Exhibit 120: Aspen Pharmacare Holdings Ltd - Overview
o Exhibit 121: Aspen Pharmacare Holdings Ltd - Business segments
o Exhibit 122: Aspen Pharmacare Holdings Ltd - Key offerings
o Exhibit 123: Aspen Pharmacare Holdings Ltd - Segment focus
o 12.5 AstraZeneca PLC
o Exhibit 124: AstraZeneca PLC - Overview
o Exhibit 125: AstraZeneca PLC - Product / Service
o Exhibit 126: AstraZeneca PLC - Key news
o Exhibit 127: AstraZeneca PLC - Key offerings
o 12.6 Bayer AG
o Exhibit 128: Bayer AG - Overview
o Exhibit 129: Bayer AG - Business segments
o Exhibit 130: Bayer AG - Key news
o Exhibit 131: Bayer AG - Key offerings
o Exhibit 132: Bayer AG - Segment focus
o 12.7 Boehringer Ingelheim International GmbH
o Exhibit 133: Boehringer Ingelheim International GmbH - Overview
o Exhibit 134: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 135: Boehringer Ingelheim International GmbH - Key news
o Exhibit 136: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 137: Boehringer Ingelheim International GmbH - Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 138: Bristol Myers Squibb Co. - Overview
o Exhibit 139: Bristol Myers Squibb Co. - Product / Service
o Exhibit 140: Bristol Myers Squibb Co. - Key news
o Exhibit 141: Bristol Myers Squibb Co. - Key offerings
o 12.9 Daiichi Sankyo Co. Ltd.
o Exhibit 142: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 143: Daiichi Sankyo Co. Ltd. - Product / Service
o Exhibit 144: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 145: Daiichi Sankyo Co. Ltd. - Key offerings
o 12.10 Dr Reddys Laboratories Ltd.
o Exhibit 146: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 147: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 148: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 149: Dr Reddys Laboratories Ltd. - Segment focus
o 12.11 GlaxoSmithKline Plc
o Exhibit 150: GlaxoSmithKline Plc - Overview
o Exhibit 151: GlaxoSmithKline Plc - Business segments
o Exhibit 152: GlaxoSmithKline Plc - Key news
o Exhibit 153: GlaxoSmithKline Plc - Key offerings
o Exhibit 154: GlaxoSmithKline Plc - Segment focus
o 12.12 Johnson and Johnson Services Inc.
o Exhibit 155: Johnson and Johnson Services Inc. - Overview
o Exhibit 156: Johnson and Johnson Services Inc. - Business segments
o Exhibit 157: Johnson and Johnson Services Inc. - Key news
o Exhibit 158: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 159: Johnson and Johnson Services Inc. - Segment focus
o 12.13 LEO Pharma AS
o Exhibit 160: LEO Pharma AS - Overview
o Exhibit 161: LEO Pharma AS - Business segments
o Exhibit 162: LEO Pharma AS - Key offerings
o Exhibit 163: LEO Pharma AS - Segment focus
o 12.14 Novartis AG
o Exhibit 164: Novartis AG - Overview
o Exhibit 165: Novartis AG - Business segments
o Exhibit 166: Novartis AG - Key offerings
o Exhibit 167: Novartis AG - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 168: Pfizer Inc. - Overview
o Exhibit 169: Pfizer Inc. - Product / Service
o Exhibit 170: Pfizer Inc. - Key news
o Exhibit 171: Pfizer Inc. - Key offerings
o 12.16 Sanofi SA
o Exhibit 172: Sanofi SA - Overview
o Exhibit 173: Sanofi SA - Business segments
o Exhibit 174: Sanofi SA - Key news
o Exhibit 175: Sanofi SA - Key offerings
o Exhibit 176: Sanofi SA - Segment focus
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 177: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 178: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 179: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 180: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 181: Teva Pharmaceutical Industries Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 182: Inclusions checklist
o Exhibit 183: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 184: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 185: Research methodology
o Exhibit 186: Validation techniques employed for market sizing
o Exhibit 187: Information sources
o 13.5 List of abbreviations
o Exhibit 188: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global anticoagulants market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Injectable anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Injectable anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Injectable anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Injectable anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Type - Market share 2022-2027 (%)
Exhibits45: Data Table on Type - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Factor Xa inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Factor Xa inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Factor Xa inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Factor Xa inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on DTIs - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on DTIs - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on DTIs - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on DTIs - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Heparin - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Heparin - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Heparin - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Heparin - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Vitamin K antagonists - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Vitamin K antagonists - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Vitamin K antagonists - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Vitamin K antagonists - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: Aspen Pharmacare Holdings Ltd - Overview
Exhibits121: Aspen Pharmacare Holdings Ltd - Business segments
Exhibits122: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibits123: Aspen Pharmacare Holdings Ltd - Segment focus
Exhibits124: AstraZeneca PLC - Overview
Exhibits125: AstraZeneca PLC - Product / Service
Exhibits126: AstraZeneca PLC - Key news
Exhibits127: AstraZeneca PLC - Key offerings
Exhibits128: Bayer AG - Overview
Exhibits129: Bayer AG - Business segments
Exhibits130: Bayer AG - Key news
Exhibits131: Bayer AG - Key offerings
Exhibits132: Bayer AG - Segment focus
Exhibits133: Boehringer Ingelheim International GmbH - Overview
Exhibits134: Boehringer Ingelheim International GmbH - Business segments
Exhibits135: Boehringer Ingelheim International GmbH - Key news
Exhibits136: Boehringer Ingelheim International GmbH - Key offerings
Exhibits137: Boehringer Ingelheim International GmbH - Segment focus
Exhibits138: Bristol Myers Squibb Co. - Overview
Exhibits139: Bristol Myers Squibb Co. - Product / Service
Exhibits140: Bristol Myers Squibb Co. - Key news
Exhibits141: Bristol Myers Squibb Co. - Key offerings
Exhibits142: Daiichi Sankyo Co. Ltd. - Overview
Exhibits143: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits144: Daiichi Sankyo Co. Ltd. - Key news
Exhibits145: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits146: Dr Reddys Laboratories Ltd. - Overview
Exhibits147: Dr Reddys Laboratories Ltd. - Business segments
Exhibits148: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits149: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits150: GlaxoSmithKline Plc - Overview
Exhibits151: GlaxoSmithKline Plc - Business segments
Exhibits152: GlaxoSmithKline Plc - Key news
Exhibits153: GlaxoSmithKline Plc - Key offerings
Exhibits154: GlaxoSmithKline Plc - Segment focus
Exhibits155: Johnson and Johnson Services Inc. - Overview
Exhibits156: Johnson and Johnson Services Inc. - Business segments
Exhibits157: Johnson and Johnson Services Inc. - Key news
Exhibits158: Johnson and Johnson Services Inc. - Key offerings
Exhibits159: Johnson and Johnson Services Inc. - Segment focus
Exhibits160: LEO Pharma AS - Overview
Exhibits161: LEO Pharma AS - Business segments
Exhibits162: LEO Pharma AS - Key offerings
Exhibits163: LEO Pharma AS - Segment focus
Exhibits164: Novartis AG - Overview
Exhibits165: Novartis AG - Business segments
Exhibits166: Novartis AG - Key offerings
Exhibits167: Novartis AG - Segment focus
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: Sanofi SA - Overview
Exhibits173: Sanofi SA - Business segments
Exhibits174: Sanofi SA - Key news
Exhibits175: Sanofi SA - Key offerings
Exhibits176: Sanofi SA - Segment focus
Exhibits177: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits178: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits179: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits180: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits181: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations